Suppr超能文献

120 个国家结核病死亡的经济影响,以及未能实现可持续发展目标结核病具体目标的代价:全收入分析。

Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis.

机构信息

Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.

Faculty of Medicine, School of Public Health, Imperial College London, London, UK.

出版信息

Lancet Glob Health. 2021 Oct;9(10):e1372-e1379. doi: 10.1016/S2214-109X(21)00299-0. Epub 2021 Sep 3.

Abstract

BACKGROUND

The tuberculosis targets for the UN Sustainable Development Goals (SDGs) call for a 90% reduction in tuberculosis deaths by 2030, compared with 2015, but meeting this target now seems highly improbable. To assess the economic impact of not meeting the target until 2045, we estimated full-income losses in 120 countries, including those due to excess deaths resulting from COVID-19-related disruptions to tuberculosis services, for the period 2020-50.

METHODS

Annual mortality risk changes at each age in each year from 2020 to 2050 were estimated for 120 countries. This risk change was then converted to full-income risk by calculating a population-level mortality risk change and multiplying it by the value of a statistical life-year in each country and year. As a comparator, we assumed that current rates of tuberculosis continue to decline through the period of analysis. We calculated the full-income losses, and mean life expectancy losses per person, at birth and at age 35 years, under scenarios in which the SDG targets are met in 2030 and in 2045. We defined the cost of inaction as the difference in full-income losses and tuberculosis mortality between these two scenarios.

FINDINGS

From 2020 to 2050, based on the current annual decrease in tuberculosis deaths of 2%, 31·8 million tuberculosis deaths (95% uncertainty interval 25·2 million-39·5 million) are estimated to occur, corresponding to an economic loss of US$17·5 trillion (14·9 trillion-20·4 trillion). If the SDG tuberculosis mortality target is met in 2030, 23·8 million tuberculosis deaths (18·9 million-29·5 million) and $13·1 trillion (11·2 trillion-15·3 trillion) in economic losses can be avoided. If the target is met in 2045, 18·1 million tuberculosis deaths (14·3 million-22·4 million) and $10·2 trillion (8·7 trillion-11·8 trillion) can be avoided. The cost of inaction of not meeting the SDG tuberculosis mortality target until 2045 (vs 2030) is, therefore, 5·7 million tuberculosis deaths (5·1 million-8·1 million) and $3·0 trillion (2·5 trillion-3·5 trillion) in economic losses. COVID-19-related disruptions add $290·3 billion (260·2 billion-570·1 billion) to this cost.

INTERPRETATION

Failure to achieve the SDG tuberculosis mortality target by 2030 will lead to profound economic and health losses. The effects of delay will be greatest in sub-Saharan Africa. Affected countries, donor nations, and the private sector should redouble efforts to finance tuberculosis programmes and research because the economic dividend of such strategies is likely to be substantial.

FUNDING

None.

摘要

背景

联合国可持续发展目标(SDG)呼吁到 2030 年将结核病死亡率降低 90%,与 2015 年相比,但现在看来,要实现这一目标似乎极不可能。为了评估到 2045 年仍未达到目标的经济影响,我们估算了包括因与结核病服务相关的 COVID-19 中断导致的超额死亡在内的 120 个国家在 2020-2050 年期间的全部收入损失。

方法

估计了 120 个国家在 2020 年至 2050 年期间每个年龄组的每年死亡率变化。通过计算人群死亡率变化并乘以每个国家和年份的统计生命年的价值,将这种风险变化转化为全收入风险。作为比较,我们假设当前的结核病发病率持续下降,直至分析期间。我们在 2030 年和 2045 年实现 SDG 目标的情况下,计算了出生时和 35 岁时的全收入损失和每人平均预期寿命损失。我们将不作为的成本定义为这两个情景之间的全收入损失和结核病死亡率之间的差异。

结果

从 2020 年到 2050 年,根据目前每年结核病死亡人数减少 2%的情况,预计将发生 3180 万例结核病死亡(95%不确定区间为 2520 万-3950 万),这将导致经济损失 17.5 万亿美元(14.9-20.4 万亿美元)。如果 2030 年实现了 SDG 结核病死亡率目标,那么可以避免 2380 万例结核病死亡(1890-2950 万)和 13.1 万亿美元(11.2-15.3 万亿美元)的经济损失。如果到 2045 年实现目标,则可以避免 1810 万例结核病死亡(1430-2240 万)和 10.2 万亿美元(8.7-11.8 万亿美元)。因此,未能在 2045 年(而非 2030 年)实现 SDG 结核病死亡率目标的不作为成本是 570 万例结核病死亡(510-810 万)和 3 万亿美元(2.5-3.5 万亿美元)的经济损失。与结核病相关的中断将使这一成本增加 2903 亿美元(2602-5701 亿美元)。

解释

如果到 2030 年仍未实现 SDG 结核病死亡率目标,将导致严重的经济和健康损失。这种延迟的影响在撒哈拉以南非洲地区最大。受影响的国家、捐助国和私营部门应加倍努力为结核病方案和研究提供资金,因为这些策略的经济红利可能相当可观。

资金

无。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/8415897/ac793c6ea330/gr1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验